Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

INDIV × Immunosuppressive Agents × Clear all

Status

Sponsor Class

OTHER 2 INDIV 1

Study Type

Observational 1

Sponsor

Conditions

Myasthenia Gravis 1

Interventions

Proflavine 7 pembrolizumab 2 Tacrolimus 2 Pyridostigmine Bromide 2 Prednisone 2 Microbial Collagenase 2 sargramostim 1 plerixafor 1 pegfilgrastim 1 olaparib 1 nilotinib 1 macimorelin 1 keyhole-limpet hemocyanin 1 ethyl pyruvate 1 compound W 1 blinatumomab 1 Watchful Waiting 1 Uracil 1 Tegafur 1 Surgical Procedures, Operative 1 Steroids 1 Sodium Chloride 1 Sirolimus 1 Salicylates 1 Peptides 1 PM 01183 1 Mycophenolic Acid 1 Monatide (IMS 3015) 1 Mifepristone 1 Methylprednisolone 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04101578 2021-08-23

Clinical Prognosis and Progression of Myasthenia Gravis Patients

Da, Yuwei, M.D.

Myasthenia Gravis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡